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CHAPTER TWENTY -ONE
 
Division of Environmental
 
Medicine and Toxicology
 
LANCE L. SIMPSON, PH.D. 
((It is evident that efforts to preserve 
health will be most intelligently and 
effectually applied when they are based 
upon an accurate and full knowledge of 
the agencies which cause disease.J) 
-WILI.IAM H. WELCH (18\0-193+) 
refine methods for the diagnosis and treatment ofResearch, Diagnosis, and poisoned patients. 
Trcatn1ent There arc several reasons why the creation of 
this Division should be seen as a bold venture. 
In the bll of 1984, the Department of Medicine Neither Occupational Medicine nor Medical 
embarked on a new venture, the Division of Toxicology has typically been granted more than 
Environmental Medicine and Toxicology. The "backroom" status in Departments of Medicine. 
Division was planned to comprise three separate Also, relatively few schools of medicine have had 
but interacting components, as follows: (I) a basic full-fledged programs in toxicology at all, the 
science research component with scientists whose subject usually having been treated as an 
go:t1 would be to determine the mechanism of appendage to the Department of Pharmacology. 
action of toxins; (2) a clinical services component Flourishing groups in the basic science specialty of 
with physicians board certified in Occupational toxicology have generally been limited to schools 
Medicine and in Medical Toxicology; and (3) a of public health or pharmacy. The initiative of the 
cLnical toxicology unit with physicians and Department of Medicine in developing a Division 
scientists who work collaborativdy to improve and of Environmental Medicine and Toxicology equal 
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in status to the other 12 Departmental Divisions 
represented a break with tradition. It was also a 
wise anticipation of future needs and 
opportunities. 
Strides toward the reduction of morbidity and 
mortality have been made in many areas of 
medicine. Antibiotics and vaccines against 
infectious diseases, antiarrhythmic and vasoactive 
drugs against heart disease, anti-inflammatory 
drugs, and dialysis may be cited as 
accomplishments. Such advances have caused a 
refocusing of attention. With the elimination or 
control of some illnesses, the remaining problems, 
often of obscure cause, command greater 
attention. There is clear evidence that many forms 
of illness are toxin-mediated, with some of the 
toxins being of natural origin and some man­
made. The majority of such toxin-mediated 
diseases have not been brought under control. It 
was in the hope of contributing new initiatives in 
this area that Jefferson embarked on this course. 
The past decade has been dominated by what 
has been called "descriptive and regulatory 
toxicology." Descriptive toxicology involves the 
administration of potentially toxic substances to 
subjects and thereafter attempting to identify and 
quantifY adverse effects. Regulatory toxicology 
involves the effort to translate laboratory data into 
risk assessment and then using this to establish 
guidelines for human exposure to toxic agents. 
There are serious drawbacks to the overemphasis 
of descriptive and regulatory toxicology. Not the 
least of these is the fact that they involve serious 
decision making, such as setting limits for human 
exposure, without knowing the underlying 
mechanism of toxin action. The Division of 
Environmental Medicine and Toxicology has been 
built in a way that is calculated to avoid these 
difficulties. All of the newly appointed staff 
members are devoted to research aimed at 
clarifYing the mechanisms by which toxins act, 
thus providing a more substantive basis for such 
measures as risk assessment. In addition, it 
provides the scientific basis for advances in 
diagnosis and treatment. 
The first full-time appointment to the Division 
was that of Lance L. Simpson, Ph.D., (University 
of California, Berkeley), who is currently Professor 
of Medicine and Pharmacology and Chief of 
Environmental Medicine and Toxicology. Dr. 
Simpson took his undergraduate degree at 
Vanderbilt University in Nashville, Tennessee, and 
did his doctoral work at the University of 
California in Berkeley. He next did a postdoctoral 
Fellowship at the College of Physicians and 
Surgeons of Columbia University. His graduate 
work was done in the Laboratory of Chemical 
Biodynamics, under the supervision of Professor 
Melvin Calvin, a Nobel Laureate. His 
postgraduate work was done under the joint 
supervision of Dr. Maurice Rapport, Professor of 
Psychiatry and Biochemistry, and Dr. S. C. Wang, 
Professor of Pharmacology, botl1 at the College of 
Physicians and Surgeons. Mter completing his 
studies in 1971, Dr. Simpson joined the staff at the 
Columbia-Presbyterian Medical Center. He 
remained there until moving to Jefferson's Medical 
Department in the fall of 1984. 
Dr. Simpson has been working on toxins since 
his undergraduate days at Vanderbilt University. 
Most of his effort has been directed toward the 
study of protein toxins that act on the nervous 
system. These substances include poisons of 
microbial origin, such as botulinum toxin and 
tetanus toxin, as well as poisons of snake venom 
origin, such as alpha and beta bungarotoxin. This 
work has several motives, including determining 
the mechanism of toxin action, determining the 
structure of toxin molecules and then correlating 
structure with function, developing drugs for the 
treatment of poisoned patients, and constructing 
synthetic vaccines that can be used to in1munizc 
patients. More recently, another aspect of toxin­
related research has been added. Thcre are certain 
toxins, or pieces of toxins, that appear to have 
value as potential therapeutic agents. For example, 
tissue-targeted toxins that can locate and kill 
neoplastic cells may have clinical utility in tlle 
treatment of cancer. This area of research has now 
been added to the overall scope of activities. 
Although work on protein toxins has been the 
main theme of Dr. Simpson's research, there was 
one stretch of time when another aspect of 
toxicology was undertaken. From the late 1970S 
wltil the early 1980s Dr. Sinlpson was involved in 
a collaborative research project with the New York 
City Police Department. The purpose of the work 
was to assess tl1e effects of illicit dmg use on 
criminal behavior, and thus the project was one in 
behavioral toxicology. The method used by the 
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investigators was to observe crime while it was 
occurring. These observations were then compared 
with data on drug usc by the otlenders. The 
crimes of interest were larceny, assault, robbery, 
and gun-related incidents; the drugs of interest 
were opioids and central nervous system 
stimulants. A wealth of data was collected and the 
tindings arc to be published in a book tint will 
appe;lr in 1988. 
During Dr. Simpson's relatively short tenure as 
Chief of the Di vision., he has added t()Llr members 
to the St;lH". Three of these were principally 
oriented toward research, and one mainly clinical. 
The tirst ;lddition to the research staff was Kevin 
Chlllll, Ph.D., Assistallt Proressor of Medicine. 
Dr. Chinn did his gLlduate work in the 
Department of Phy~siology at the University of 
Hawaii, where he worked under the guidance of 
Dr. Howard Gillary. While there he took an 
illterest In the usc of highly sophisticated 
e1ectrophysl010gieal techniques as a means t()r 
studying the efrects of drugs on the nervous 
system. 
In 1981 Dr. Chinn moved on to a postdoctoral 
Fcllowshlp in the laboratory of Dr. John Lisman 
at Br;1I1deis University, and two years later he 
joined the IabOLltOry of Dr. Toshio Naralnshi at 
Northwestern University. During the both of 
these rellowships Dr. Chinn was able to enhance 
his electrophysio]ogical skills. In the fall of 1986, 
he moved to his presellt position at JdTerson. 
Dr. Chinn is one of the rew toxicologists in the 
nation who IS Clp;lblc of using the patch clamp 
techJ1Jque t<>r the study of excitable tissues. This 
techniqlll' in 111Ieroelectrophysiology allows him to 
stud" the ,lCtions of toxins on individual ion 
channels in nerves ;1I1d heart. He is employing the 
method to analyze the effects of agents such as 
insecticides on sodium channel behavior. Chinn is 
responsible for the tinding that one insecticide in 
particular, Dclumethrin, is capable of blocking the 
transition of sod ium channels between the open 
and closed states. These and other of Dr. Chinn's 
tindings help to explain the cellular and molecular 
basis t<)r the toxicity of certain poisons. 
In addition to this major thrust of his work, Dr. 
Chinn has developed methods that permit the 
injection of real or suspected toxins into individual 
cells that are grown in tissue culture. This is an 
especially powerful technique, and it promises to 
help resolve the mechanism of action of many 
toxic agents. It is potentially a method for 
examining the effects of therapeutic agents as well. 
The next member to join the Division was Dr. 
Charles Mactutus, Ph.D., Assistant Professor of 
Medicine, an investigator trained both in 
toxicology and in the experimental analysis of 
behavior. Dr. Mactutus did his graduate work 
with Dr. David Riccion in the Department of 
Psychology at Kent State University, where he did 
research in the area of learning and memory. In 
1979 he accepted a postdoctoral fellowship at the 
Johns Hopkins University, where he was able to 
apply his background in experimental psychology 
to the study of central ncrvous system toxicology. 
While at Johns Hopkins, he perf()rJlled a series of 
experiments to examine the influence of prenatal 
carbon monoxide exposure on learning and 
memory of the offspring. This work, which was 
designed to provide a model of cigarette smoking 
during pregnancy, demonstrated persistent 
alterations in memory. The research was widely 
cited, both in the scientitic press and in the lay 
press. 
Dr. Mactutlls moved from Johns Hopkins to 
accept a position at the National Institute for 
Environmental Health Sciences. He was 
instrumental in t()rming and leading a group of 
investigators who studied the dtccts of toxins on 
central nervous system development. The group 
examined a number of environmental substances, 
including tetraethyl and tricthyl lead. In early 1987 
Mactutus joined JeHerson's faculty. He is 
establishll1g a new program in central nervous 
system toxicology that cmphasizcs a 
multidisciplinary f(KUS; using a lifespan approach, 
he will pert()[Jll psychological and toxicologiul 
studies aimed at assessing the impact of prenatal 
or early neonatal exposure to toxins on subsequent 
neurological and psychological development. 
The most recent recruit to the Division is Dr. 
Masaru Tanaka, Ph.D., who is a Research 
Associate. Dr. Tanaka did his entire training at the 
University of Tokyo, and later tor many years was 
a mcmber of the Faculty at the University of 
Hawaii. Dr. Tanaka is an expert in the field of 
protein chemistry. He has developed exquisite 
methods f()r the isolation, purification, and 
characterization of proteins from both procaryotic 
and eucaryotic sources. His past work has focllsed 
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on substances isolated from bacteria as well as 
substances derived from the mammalian 
cardiovascular system. Dr. Tanaka has joined the 
Division to work with Dr. Simpson and will 
oversee research on the isolation and 
characterization of protein toxins. 
• Clinical Services 
In the spring of 1987 the Division formally 
initiated its clinical activities by inaugurating an 
Occupational and Environmental Medicine Clinic. 
The physician who currently holds principal 
responsibility in the Clinic is Dr. Jack Snyder. Dr. 
Snyder (M.D., Northwestern) is an unusually 
well-trained individual. His medical degree was 
followed by a law degree at Georgetown 
University. He completed his Master's Degree in 
Forensic Science at George Washington University 
and his Master's in Public Health at Johns 
Hopkins University. Finally, Dr. Snyder took a 
Ph.D. degree in the Department of Pharmacology 
and Toxicology at the Medical College of Virginia. 
He is licensed to practice both law and medicine. 
Dr. Snyder has done postgraduate work in 
occupational medicine, internal medicine, and 
pathology. He is board certified by the American 
Board of Pathology in Anatomic and Clinical 
Pathology and by the American Board of Medical 
Toxicology. 
Dr. Snyder's main interest in the area of clinical 
medicine is the acutely and seriously poisoned 
patient. This interest finds its expression in three 
different settings: (I) he is responsible for seeing 
patients who come to the Occupational and 
Environmental Medicine Clinic; (2) he has a close 
association with the Emergency Room; poisoned 
patients who are treated initially in the Emergency 
Room and who are subsequently candidates for 
inpatient care are admitted to Dr. Snyder's service; 
and (3) he is a member of the Advisory Board of 
the Delaware Valley Regional Poison Control 
Center. In collaboration with other medical and 
related professionals, Snyder oversees the activities 
of the poison information service for Philadelphia 
and the surrounding areas. 
In addition to clinical responsibilities, Dr. 
Snyder is building a research program. Following 
up on his Ph.D. thesis work, he is establishing a 
laboratory that focuses on liver pathology. He is 
interested in the adverse effects of alcohol on the 
function of liver membranes, and especially those 
untoward effects that might be mediated by 
enzymes such as phospholipase. Beyond this, he is 
attempting to learn whether there are adverse 
interactions between alcohol and environmental 
toxins. Snyder is pursuing the hypothesis that 
some aspects of what has traditionally been called 
alcohol-induced liver pathology is in reality tl1e 
outcome of an interaction between alcohol and 
environmental substances. 
• A Future Clinical Research Unit 
The Clinic will not function separately from 
teaching and research. It will provide both medical 
students and house staff with practical 
opportunities in the diagnosis and treatment of 
occupational and environmental health problems. 
The possibility that man-made substances can 
cause disease has given rise to two rather robust 
areas of research. Basic scientists have contributed 
a great deal to our understanding of mechanisms 
of toxin action. Clinical scientists and investigators 
trained in public health have provided a wealth of 
epidemiological data. Both of these have added to 
our growing knowledge of the link between 
man-made substances and human illness. However, 
each has its acknowledged shortcomings. Basic 
science focuses on the study of animals or tissues 
obtained from animals, and therefore the data 
have to be extrapolated to humans. This is 
sometimes appropriate, sometimes not. 
Epidemiology, too, has its weakness. The use of 
statistical techniques and large populations does 
help to identify broad trends and associations, but 
it cannot establish whether the illness of a 
particular individual is due to the specific hazards 
that surround that individual. 
A consensus among investigators in 
occupational and environmental medicine is that 
there must be more physicians involved in 
research. The nature of the research needed is that 
in which the physician-scientist studies individual 
patients or specimens obtained from patients. 
There is a tendency to view patients as though 
they belong to one or the other of two discrete 
states, healthy or ill, but this clearly is an 
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oversimplification. When one is dealing with 
patients exposed to hazardous substances, there 
is a gradation. There may well be a time when 
the patient is healthy and a later time when he 
is ill, but between these two extremes is a 
period of mounting vulnerability and 
suscepti bil ity. 
It would be a magnificent accomplishment in 
occupational and environmental medicine if 
physician-scientists, who are regularly seeing 
patients from the workplace, could develop 
chemical markers or related techniques for 
detecting those individuals who are in transition 
from a healthy to an ill state. In essence, this 
would be a meshing of environment medicine 
with preventive medicine. Not only would this 
safeguard the welfare of the individual worker, but 
it would spare what would otherwise have been 
lost productivity, and it would f()restall the entire 
compensation issue and possible litigation. 
The development of markers for incipient 
disease is a great challenge. Nevertheless, it is a 
legitimate undertaking for a physician-scientist, 
and therefore it is a part of the scope of activities 
of the Division of Environmental Medicine and 
Toxicology. 
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